First formed in 1984, Bicher Cancer Institute is one of the largest hyperthermic cancer treatment and research facilities in the United States. Since the beginning, BCI has been committed to the research, development, and clinical use of hyperthermia combined with low dose radiation (IMRT).
The hyperthermia cancer treatment approach used at BCI has a curative intent, as opposed to the palliative treatment of some conventional therapies. It combines hyperthermia with low dose Intensity-Modulated Radiation Therapy (IMRT) to reduce and eliminate localized tumors.
Cancer evokes an immeasurable amount of fear, anger and futility in anyone affected by it. Whether you are the patient or you know someone with cancer, the effects are overwhelming.
Treatments for cancer have traditionally been surgery, radiation therapy and chemotherapy. However in 1985, hyperthermia therapy was approved for clinical use. Hyperthermia is a natural non- invasive treatment utilizing technology to generate heat to specific areas of the body where cancer is located. This heat begins the destruction process and when combined with radiation, produces excellent results.
Radiation given alone is an effective treatment, however, when combined with targeted non-toxic hyperthermia, radiation can be given in a way which minimizes toxicity and increases the response rate. Often, the response is 2 or 3 times greater than compared to that of radiation or chemotherapy administered alone.
The good news is that you do have the choice to include hyperthermia therapy as part of a comprehensive cancer treatment program. Call Bicher Cancer Institute now to schedule an appointment or for more information on how hyperthermia works.